Continuing education virtual lecture to help prevent fungal infections in HSCT recipients

Oct 9 2009

Systemic fungal infections are a serious complication of hematopoietic stem cell transplantation (HSCT) and are associated with significant mortality in HSCT recipients. It is critical for healthcare professionals to be aware of the risk factors for fungal infections in HSCT patients and apply optimal strategies for prevention and treatment in this population.

To address the need for current education on fungal infections in HSCT recipients, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education video virtual lecture for physicians, pharmacists, and registered nurses entitled Preventing Fungal Infections in HSCT Recipients: Insights from Clinical Cases. This activity is supported by an educational grant from Schering-Plough Corporation.

Faculty for this continuing education activity are experts in infectious diseases: Kieren A. Marr, MD, from Johns Hopkins University School of Medicine in Baltimore, Maryland; Pranatharthi H. Chandrasekar, MD, from Wayne State University School of Medicine and Karmanos Cancer Institute in Detroit, Michigan; and Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, from The University of Texas MD Anderson Cancer Center in Houston, Texas.

Healthcare professionals can visit www.RMEI.com/fungal137VL to participate in the continuing education virtual lecture.

"Quality continuing education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute LLC President and CEO, Robert M. Colleluori.